CA2686885A1 - Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules - Google Patents

Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules Download PDF

Info

Publication number
CA2686885A1
CA2686885A1 CA002686885A CA2686885A CA2686885A1 CA 2686885 A1 CA2686885 A1 CA 2686885A1 CA 002686885 A CA002686885 A CA 002686885A CA 2686885 A CA2686885 A CA 2686885A CA 2686885 A1 CA2686885 A1 CA 2686885A1
Authority
CA
Canada
Prior art keywords
androgen
composition
ubidecarenone
extract
testosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002686885A
Other languages
English (en)
Inventor
Ken Clement
Shan Chaudhuri
Michele Molino
Philip Apong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations and Formulations Corp
Original Assignee
Northern Innovations And Formulations Corp.
Ken Clement
Shan Chaudhuri
Michele Molino
Philip Apong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Innovations And Formulations Corp., Ken Clement, Shan Chaudhuri, Michele Molino, Philip Apong filed Critical Northern Innovations And Formulations Corp.
Publication of CA2686885A1 publication Critical patent/CA2686885A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002686885A 2007-05-10 2007-05-10 Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules Abandoned CA2686885A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2007/000835 WO2008138095A1 (fr) 2007-05-10 2007-05-10 Composition permettant de maintenir un potentiel de fixation d'androgène et de tout élément similaire à l'androgène dans des cellules

Publications (1)

Publication Number Publication Date
CA2686885A1 true CA2686885A1 (fr) 2008-11-20

Family

ID=40001617

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002686885A Abandoned CA2686885A1 (fr) 2007-05-10 2007-05-10 Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules

Country Status (4)

Country Link
EP (1) EP2152285A4 (fr)
AU (1) AU2007353300A1 (fr)
CA (1) CA2686885A1 (fr)
WO (1) WO2008138095A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103588745B (zh) * 2013-11-26 2015-10-28 陕西嘉禾植物化工有限责任公司 一种从毛喉鞘蕊花中提取和分离弗斯可林的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002041A1 (fr) * 1995-07-03 1997-01-23 Crandall Wilson T Traitement transcutane et oral de l'alopecie androgene
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements

Also Published As

Publication number Publication date
EP2152285A4 (fr) 2010-11-17
WO2008138095A1 (fr) 2008-11-20
AU2007353300A1 (en) 2008-11-20
EP2152285A1 (fr) 2010-02-17

Similar Documents

Publication Publication Date Title
JP6978392B2 (ja) トコトリエノールの経粘膜送達
US8491943B2 (en) Method and composition for improved anabolism
US20080317886A1 (en) Compositions for Preventing and Reducing Delayed Onset Muscle Soreness
US8062679B2 (en) Composition for maintaining androgen and androgen-like uptake potential by cells
US20210220422A1 (en) Dietary supplement compositions and methods
JP2007536250A (ja) 骨格筋におけるクレアチンの取り込みを増大するための栄養組成物
AU2020423611A1 (en) Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects
WO2012036208A1 (fr) Agent d'amélioration de l'oxydation des graisses et du métabolisme énergétique
CA2686885A1 (fr) Composition permettant de maintenir un potentiel de fixation d'androgene et de tout element similaire a l'androgene dans des cellules
WO2012063198A1 (fr) Compositions pour la prévention et le traitement de dysfonctionnement érectile et de l'impuissance et pour améliorer la performance sportive
US20100189820A1 (en) Composition and Methods for Maintaining Skeletal Muscle Androgen Receptivity
CA2810793C (fr) Ingredients derives de sphaerantus indicus et compositions les contenant destinees a augmenter les performances physiques et les niveaux d'energie
US20050171030A1 (en) Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
FR2991181A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique
KR100887388B1 (ko) 간 보호를 위한 건강보조식품
EA045710B1 (ru) Применение композиций, содержащих аминокислоты, для предотвращения и лечения кардиотоксичности, индуцированной химиотерапевтическими агентами
EP1587522A1 (fr) Proanthocyanidines permettant un bien-etre sexuel et la sante du systeme vasculaire sexuel
CN117715539A (zh) 骨骼肌营养组合物
CN117915902A (zh) 营养组合物
Zhang Zhu et al.(43) Pub. Date: Feb. 10, 2005
BG1072U1 (bg) Хранителна добавка

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150416